Skip to main content
Journal cover image

Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Publication ,  Journal Article
Ling, XB; Lau, K; Deshpande, C; Park, JL; Milojevic, D; Macaubas, C; Xiao, C; Lopez-Avila, V; Kanegaye, J; Burns, JC; Cohen, H; Schilling, J ...
Published in: Clin Proteomics
December 2010

PURPOSE: Systemic juvenile idiopathic arthritis is a chronic pediatric disease. The initial clinical presentation can mimic other pediatric inflammatory conditions, which often leads to significant delays in diagnosis and appropriate therapy. SJIA biomarker development is an unmet diagnostic/prognostic need to prevent disease complications. EXPERIMENTAL DESIGN: We profiled the urine peptidome to analyze a set of 102 urine samples, from patients with SJIA, Kawasaki disease (KD), febrile illnesses (FI), and healthy controls. A set of 91 plasma samples, from SJIA flare and quiescent patients, were profiled using a customized antibody array against 43 proteins known to be involved in inflammatory and protein catabolic processes. RESULTS: We identified a 17-urine-peptide biomarker panel that could effectively discriminate SJIA patients at active, quiescent, and remission disease states, and patients with active SJIA from confounding conditions including KD and FI. Targeted sequencing of these peptides revealed that they fall into several tight clusters from seven different proteins, suggesting disease-specific proteolytic activities. The antibody array plasma profiling identified an SJIA plasma flare signature consisting of tissue inhibitor of metalloproteinase-1 (TIMP1), interleukin (IL)-18, regulated upon activation, normal T cell expressed and secreted (RANTES), P-Selectin, MMP9, and L-Selectin. CONCLUSIONS AND CLINICAL RELEVANCE: The urine peptidomic and plasma protein analyses have the potential to improve SJIA care and suggest that SJIA urine peptide biomarkers may be an outcome of inflammation-driven effects on catabolic pathways operating at multiple sites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12014-010-9058-8) contains supplementary material, which is available to authorized users.

Duke Scholars

Published In

Clin Proteomics

DOI

ISSN

1542-6416

Publication Date

December 2010

Volume

6

Issue

4

Start / End Page

175 / 193

Location

England

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ling, X. B., Lau, K., Deshpande, C., Park, J. L., Milojevic, D., Macaubas, C., … Mellins, E. D. (2010). Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics, 6(4), 175–193. https://doi.org/10.1007/s12014-010-9058-8
Ling, Xuefeng B., Kenneth Lau, Chetan Deshpande, Jane L. Park, Diana Milojevic, Claudia Macaubas, Chris Xiao, et al. “Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.Clin Proteomics 6, no. 4 (December 2010): 175–93. https://doi.org/10.1007/s12014-010-9058-8.
Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Macaubas C, et al. Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics. 2010 Dec;6(4):175–93.
Ling, Xuefeng B., et al. “Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.Clin Proteomics, vol. 6, no. 4, Dec. 2010, pp. 175–93. Pubmed, doi:10.1007/s12014-010-9058-8.
Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Macaubas C, Xiao C, Lopez-Avila V, Kanegaye J, Burns JC, Cohen H, Schilling J, Mellins ED. Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics. 2010 Dec;6(4):175–193.
Journal cover image

Published In

Clin Proteomics

DOI

ISSN

1542-6416

Publication Date

December 2010

Volume

6

Issue

4

Start / End Page

175 / 193

Location

England

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 3101 Biochemistry and cell biology